Millions of people around the world die from heart failure every year. In future, a laboratory-grown heart patch could help with severe cases of cardiovascular disease, say scientists behind a ...
In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).